{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:52:42Z","timestamp":1781646762611,"version":"3.54.5"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Vertigo is a common neurologic symptom and can be a distressing and disabling condition. Vertigo has peripheral and central etiologies. While there are useful treatments for many peripheral cases, there is a notable absence of effective treatments for central vertigo. We describe the case of a 74-year-old male presenting with severe vertigo after a lateral medullary stroke persisting through eight days of acute inpatient rehabilitation. Low-dose olanzapine (2.5\u00a0mg nightly) was then initiated with complete resolution of his debilitating dizziness two days later, followed by a successful rehabilitation course and eventual return home.<\/jats:p>","DOI":"10.1097\/phm.0000000000002953","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:00:13Z","timestamp":1778767213000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Treating Central Vertigo After Lateral Medullary Stroke with Low-Dose Olanzapine in Acute Inpatient Rehabilitation"],"prefix":"10.1097","author":[{"given":"James","family":"Guider","sequence":"first","affiliation":[{"name":"Department of Physical Medicine & Rehabilitation, Kessler Institute of Rehabilitation, West Orange, New Jersey"},{"name":"Department of Physical Medicine & Rehabilitation, Rutgers Health, Newark, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Jasey","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine & Rehabilitation, Kessler Institute of Rehabilitation, West Orange, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Altschuler","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine & Rehabilitation, Kessler Institute of Rehabilitation, West Orange, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"R1-20260527","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.sult.2013.01.004","article-title":"Brainstem stroke: anatomy, clinical and radiological findings","volume":"34","author":"Ortiz de Mendivil","year":"2013","journal-title":"Semin Ultrasound CT MRI"},{"key":"R2-20260527","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMcp1309481","article-title":"Clinical practice. Benign paroxysmal positional vertigo","volume":"370","author":"Kim","year":"2014","journal-title":"N Engl J Med"},{"key":"R3-20260527","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/NRL.0b013e31817533a3","article-title":"Central vertigo and dizziness: epidemiology, differential diagnosis, and common causes","volume":"14","author":"Karatas","year":"2008","journal-title":"Neurologist"},{"key":"R4-20260527","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.otc.2021.05.019","article-title":"Current and emerging medical therapies for dizziness","volume":"54","author":"Raymond","year":"2021","journal-title":"Otolaryngol Clin North Am"},{"key":"R5-20260527","first-page":"e22647","article-title":"Treatment of central vertigo with low dose olanzapine: report of two cases","volume":"14","author":"Jiang","year":"2022","journal-title":"Cureus"},{"key":"R6-20260527","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1016\/j.jpainsymman.2025.04.006","article-title":"Low dose olanzapine for cases of refractory nausea and vomiting and vertigo after cerebellar stroke","volume":"70","author":"Altschuler","year":"2025","journal-title":"J Pain Symptom Manage"},{"key":"R8-20260527","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1515725","article-title":"Olanzapine for the prevention of chemotherapy-induced nausea and vomiting","volume":"375","author":"Navari","year":"2016","journal-title":"N Engl J Med"},{"key":"R9-20260527","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1470-2045(23)00628-9","article-title":"Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial","volume":"25","author":"Bajpai","year":"2024","journal-title":"Lancet Oncol"},{"key":"R10-20260527","first-page":"1097","article-title":"Olanzapine pharmacokinetics: a clinical review of current insights and remaining questions","volume":"16","author":"Kolli","year":"2023","journal-title":"Pharmgenomics Pers Med"}],"container-title":["American Journal of Physical Medicine &amp; Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PHM.0000000000002953","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:00:16Z","timestamp":1781643616000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PHM.0000000000002953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":9,"URL":"https:\/\/doi.org\/10.1097\/phm.0000000000002953","relation":{},"ISSN":["0894-9115","1537-7385"],"issn-type":[{"value":"0894-9115","type":"print"},{"value":"1537-7385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"2026-01-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}